ISIN | LU1645386217 |
---|---|
Valorennummer | 37504775 |
Bloomberg Global ID | SHEMC SW |
Fondsname | UBS (Lux) Fund Solutions - J.P. Morgan USD EM Diversified Bond 1-5 UCITS ETF (hedged to CHF) A-acc |
Fondsanbieter |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fondsanbieter | UBS Asset Management Switzerland AG, Zurich |
Vertreter in der Schweiz |
UBS Fund Management (Switzerland) AG Basel Telefon: +41 61 288 49 10 |
Distributor(en) |
UBS AG Basel Telefon: +41 61 288 20 20 UBS AG, Zürich Zürich Telefon: +41 44 234 11 11 |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | Bond Emerging Global |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | Transaktionsgebühr zugunsten des Fonds (Beitrag zur Deckung der Spesen bei der Anlage neu zufliessender Mittel) |
Konditionen bei der Rücknahme | Kombination von Rücknahmekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Investment-Strategie *** | The sub-fund aims to track, before expenses, the price and income performance of the J.P. Morgan USD EM Diversified 3% capped 1-5 Year Bond Index (Total Return) (this sub-fund's "Index"). Additionally currency hedged share classes aim to reduce the impact of currency fluctuations between their reference currency and the index currency by selling currency forwards at the one-month forward rate in accordance with the hedging methodology of the Index's currency-hedged index variant as referred to in relation to each hedged share class below. |
Besonderheiten |
Aktueller Preis * | 10.35 CHF | 09.05.2025 |
---|---|---|
Vorheriger Preis * | 10.34 CHF | 08.05.2025 |
52 Wochen Hoch * | 10.42 CHF | 03.03.2025 |
52 Wochen Tief * | 10.02 CHF | 10.05.2024 |
NAV * | 10.35 CHF | 09.05.2025 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 317'246'223 | |
Anteilsklassevermögen *** | 5'571'872 | |
Trading Information SIX |
YTD-Performance | +1.04% |
31.12.2024 - 09.05.2025
31.12.2024 09.05.2025 |
---|---|---|
1 Monat | +1.54% |
09.04.2025 - 09.05.2025
09.04.2025 09.05.2025 |
3 Monate | -0.10% |
10.02.2025 - 09.05.2025
10.02.2025 09.05.2025 |
6 Monate | +0.92% |
12.11.2024 - 09.05.2025
12.11.2024 09.05.2025 |
1 Jahr | +3.23% |
09.05.2024 - 09.05.2025
09.05.2024 09.05.2025 |
2 Jahre | +7.80% |
09.05.2023 - 09.05.2025
09.05.2023 09.05.2025 |
3 Jahre | +4.58% |
09.05.2022 - 09.05.2025
09.05.2022 09.05.2025 |
5 Jahre | +1.83% |
11.05.2020 - 09.05.2025
11.05.2020 09.05.2025 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Kuwait (State Of) | 1.01% | |
---|---|---|
Poland (Republic of) | 0.80% | |
PETRONAS Capital Ltd. | 0.74% | |
Oman (Sultanate Of) | 0.74% | |
Ghana (Republic of) | 0.73% | |
Romania (Republic Of) | 0.71% | |
Teva Pharmaceutical Finance Netherlands III B.V. | 0.71% | |
Dominican Republic | 0.66% | |
Philippines (Republic Of) | 0.63% | |
Standard Chartered PLC | 0.63% | |
Letzte Daten-Aktualisierung | 06.05.2025 |
TER | 0.38% |
---|---|
Datum TER | 30.06.2024 |
Performance Fee *** | 0.00% |
PTR | |
Max. Management Fee *** | 0.38% |
Ongoing Charges *** | 0.38% |
SRRI ***
|
|
Datum SRRI *** | 30.04.2025 |